Jacob I. Contreras

665 total citations
12 papers, 536 citations indexed

About

Jacob I. Contreras is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Jacob I. Contreras has authored 12 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Jacob I. Contreras's work include Advanced Breast Cancer Therapies (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Cancer-related Molecular Pathways (3 papers). Jacob I. Contreras is often cited by papers focused on Advanced Breast Cancer Therapies (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Cancer-related Molecular Pathways (3 papers). Jacob I. Contreras collaborates with scholars based in United States and China. Jacob I. Contreras's co-authors include Amarnath Natarajan, Sandeep Rana, Yogesh A. Sonawane, Margaret Taylor, Caroline M. Robb, Smit Kour, Mohammad Abid, Daryl J. Murry, Muhammad Zahid and Smitha Kizhake and has published in prestigious journals such as Chemical Communications, Journal of Medicinal Chemistry and Molecular Pharmacology.

In The Last Decade

Jacob I. Contreras

12 papers receiving 527 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacob I. Contreras United States 10 344 195 124 85 80 12 536
Smitha Kizhake United States 14 310 0.9× 162 0.8× 132 1.1× 71 0.8× 36 0.5× 20 490
Sarah Diab Australia 14 325 0.9× 177 0.9× 117 0.9× 103 1.2× 57 0.7× 19 522
Eva Řezníčková Czechia 15 259 0.8× 146 0.7× 245 2.0× 85 1.0× 50 0.6× 44 541
David E. Stockett United States 6 252 0.7× 189 1.0× 71 0.6× 38 0.4× 59 0.7× 9 393
Sian Anderson United Kingdom 5 275 0.8× 254 1.3× 104 0.8× 94 1.1× 34 0.4× 7 502
David Bartkovitz United States 7 427 1.2× 356 1.8× 118 1.0× 43 0.5× 39 0.5× 7 604
Sarah E. Dixon-Clarke United Kingdom 5 357 1.0× 208 1.1× 47 0.4× 70 0.8× 24 0.3× 5 444
Marcel Koenig United States 11 281 0.8× 150 0.8× 121 1.0× 26 0.3× 43 0.5× 17 500
Stephen M. Courtney United Kingdom 12 346 1.0× 95 0.5× 215 1.7× 109 1.3× 46 0.6× 15 572
Nilesh Zaware United States 12 463 1.3× 102 0.5× 141 1.1× 26 0.3× 71 0.9× 19 625

Countries citing papers authored by Jacob I. Contreras

Since Specialization
Citations

This map shows the geographic impact of Jacob I. Contreras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob I. Contreras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob I. Contreras more than expected).

Fields of papers citing papers by Jacob I. Contreras

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob I. Contreras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob I. Contreras. The network helps show where Jacob I. Contreras may publish in the future.

Co-authorship network of co-authors of Jacob I. Contreras

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob I. Contreras. A scholar is included among the top collaborators of Jacob I. Contreras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob I. Contreras. Jacob I. Contreras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Singh, Sarbjit, Jayapal Reddy Mallareddy, Yogesh A. Sonawane, et al.. (2021). Structure activity relationship (SAR) study identifies a quinoxaline urea analog that modulates IKKβ phosphorylation for pancreatic cancer therapy. European Journal of Medicinal Chemistry. 222. 113579–113579. 13 indexed citations
2.
Rana, Sandeep, Smit Kour, Yogesh A. Sonawane, et al.. (2020). Symbiotic prodrugs (SymProDs) dual targeting of NFkappaB and CDK. Chemical Biology & Drug Design. 96(2). 773–784. 13 indexed citations
3.
Robb, Caroline M., Smit Kour, Jacob I. Contreras, et al.. (2020). Correction: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 11(25). 2462–2463. 3 indexed citations
4.
Kour, Smit, Sandeep Rana, Jacob I. Contreras, et al.. (2019). CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax. Molecular Pharmacology. 96(4). 419–429. 21 indexed citations
5.
Abid, Mohammad, Yogesh A. Sonawane, Jacob I. Contreras, Sandeep Rana, & Amarnath Natarajan. (2018). Recent Advances in Cancer Drug Development: Targeting Induced Myeloid Cell Leukemia-1 (Mcl-1) Differentiation Protein. Current Medicinal Chemistry. 24(40). 4488–4514. 12 indexed citations
6.
Robb, Caroline M., Jacob I. Contreras, Smit Kour, et al.. (2017). Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC). Chemical Communications. 53(54). 7577–7580. 177 indexed citations
8.
Robb, Caroline M., Smit Kour, Jacob I. Contreras, et al.. (2017). Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy. Oncotarget. 9(4). 5216–5232. 25 indexed citations
9.
Hein, Ashley L., Margaret Taylor, Jacob I. Contreras, et al.. (2017). Discovery and characterization of small molecule Rac1 inhibitors. Oncotarget. 8(21). 34586–34600. 23 indexed citations
10.
Chhonker, Yashpal S., et al.. (2017). Developing Polyamine‐Based Peptide Amphiphiles with Tunable Morphology and Physicochemical Properties. Macromolecular Bioscience. 17(8). 6 indexed citations
11.
Sonawane, Yogesh A., et al.. (2016). Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy. Journal of Medicinal Chemistry. 59(19). 8667–8684. 124 indexed citations
12.
Rana, Sandeep, Calvin Tebbe, Jacob I. Contreras, et al.. (2016). Isatin Derived Spirocyclic Analogues with α-Methylene-γ-butyrolactone as Anticancer Agents: A Structure–Activity Relationship Study. Journal of Medicinal Chemistry. 59(10). 5121–5127. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026